SEOM clinical guidelines on cardiovascular toxicity (2018)
Clin. transl. oncol. (Print)
; 21(1): 94-105, ene. 2019. tab, graf
Article
en En
| IBECS
| ID: ibc-183348
Biblioteca responsable:
ES1.1
Ubicación: BNCS
ABSTRACT
One of the most common side effects of cancer treatment is cardiovascular disease, which substantially impacts long-term survivor's prognosis. Cardiotoxicity can be related with either a direct side effect of antitumor therapies or an accelerated development of cardiovascular diseases in the presence of preexisting risk factors. Even though it is widely recognized as an alarming clinical problem, scientific evidence is scarce in the management of these complications in cancer patients. Consequently, current recommendations are based on expert consensus. This Guideline represents SEOM's ongoing commitment to progressing and improving supportive care for cancer patients
RESUMEN
No disponible
Texto completo:
1
Bases de datos:
IBECS
Asunto principal:
Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos
/
Cardiotoxicidad
/
Antineoplásicos
Límite:
Humans
Idioma:
En
Revista:
Clin. transl. oncol. (Print)
Año:
2019
Tipo del documento:
Article